PATENT CLAIM ANALYSIS

Application Number: 15766799
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "211100"]

Abstract:
Inhibitors of Wnt signaling pathway with structures of Formula I are disclosed, together with their pharmaceutical salts. Applications of compounds of Formula I in inhibiting or modulating the Wnt signaling pathway are also disclosed. Compounds of Formula I can treat disorders caused by aberrant activation of the Wnt signaling pathway.

Claim (Index 15):
A method for treating a Wnt-mediated disorder in a mammal suffering therefrom, comprising administering to the mammal a therapeutically effective amount of at least one compound of  claim 1 , or a pharmaceutical composition thereof, and optionally in combination with a second therapeutic agent.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.63636
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15620761', '15923668', '15501233', '15326262', '14342656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7663100809433367
- 35 USC 102 Novelty (BERT): 0.5410079897058425
- Combined Prediction Score: 0.7437798718195874
- Mean Citation Score: 372.209424
- Max Citation Score: 379.16312
- Similarity Product: 206.3971612045049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test